- Home
- RXRX vs AHCO Comparison
RXRX vs AHCO Comparison
Compare RXRX & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RXRX | AHCO |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RXRX | AHCO |
|---|---|---|
| Price | $3.00 | $10.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $7.50 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 21.3M | 995.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $74,681,000.00 | ★ $3,244,857,000.00 |
| Revenue This Year | $12.11 | $9.00 |
| Revenue Next Year | $82.52 | $6.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.77 | $8.51 |
| 52 Week High | $7.18 | $13.43 |
Technical Indicators
Market Signals| Indicator | RXRX | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 41.22 | 50.88 |
| Support Level | $2.87 | $10.59 |
| Resistance Level | $4.03 | $10.70 |
| Average True Range (ATR) | 0.15 | 0.44 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 21.83 | 39.83 |
Price Performance
Historical ComparisonAbout RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.